BIOMAT Database Logo BIOMAT Database Logo

Effect of the calcium antagonist nilvadipine on haemodynamics at rest and during cold stimulation in essential hypertension. 1987

T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
First Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.

The immediate haemodynamic effects of the calcium antagonist nilvadipine have been studied in ten patients with established mild essential hypertension. Nilvadipine 4 mg p.o. reduced both the systolic and diastolic blood pressures within 60 min, associated with a fall in total peripheral resistance and an increase in heart rate and cardiac index. The peak of blood pressure and total peripheral resistance reached during a cold pressor test were reduced by nilvadipine, but it did not affect the haemodynamic responsiveness to cold stimulation. Plasma renin activity was unaltered and the plasma noradrenaline concentration was increased only slightly. Thus, nilvadipine lowered blood pressure at rest and during cold stimulation as a result of arteriolar dilatation. The hypotensive effect at rest was associated with a reflex increase in heart rate and cardiac index.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
August 1997, Arzneimittel-Forschung,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
January 1980, Postgraduate medical journal,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Effect of a new calcium antagonist on hemodynamics at rest and exercise loading in patients with essential hypertension.
November 1993, Arzneimittel-Forschung,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Haemodynamics in juvenile hypertension at rest and during exercise.
January 1980, Cor et vasa,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.
February 1988, Journal of hypertension,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria.
March 1992, Journal of internal medicine,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
August 1980, European journal of clinical pharmacology,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Central haemodynamics in essential hypertension at rest and during exercise: a 20-year follow-up study.
December 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
March 1995, Journal of human hypertension,
T Takabatake, and Y Yamamoto, and S Nakamura, and N Hashimoto, and S Satoh, and Y Yamada, and H Ohta, and N Hattori
Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension.
January 1987, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!